The Organic Chemistry of Drug Design and Drug Action PDF ePub eBook

Books Info:

The Organic Chemistry of Drug Design and Drug Action free pdf The Organic Chemistry of Drug Design and Drug Action, Third Edition, represents a unique approach to medicinal chemistry based on physical organic chemical principles and reaction mechanisms that rationalize drug action, which allows the reader to extrapolate those core principles and mechanisms to many related classes of drug molecules. This new edition reflects significant changes in the process of drug design over the last decade. It preserves the successful approach of the previous editions while including significant changes in format and coverage. New to this edition: * Updates to all chapters, including new examples and references* Chapter 1 (Introduction): Completely rewritten and expanded as an overview of topics discussed in detail throughout the book* Chapter 2 (Lead Discovery and Lead Modification): Sections on sources of compounds for screening including library collections, virtual screening, and computational methods, as well as hit-to-lead and scaffold hopping- expanded sections on sources of lead compounds, fragment-based lead discovery, and molecular graphics- and deemphasized solid-phase synthesis and combinatorial chemistry* Chapter 3 (Receptors): Drug-receptor interactions, cation-? and halogen bonding- atropisomers- case history of the insomnia drug suvorexant* Chapter 4 (Enzymes): Expanded sections on enzyme catalysis in drug discovery and enzyme synthesis* Chapter 5 (Enzyme Inhibition and Inactivation): New case histories: * for competitive inhibition, the epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib and Abelson kinase inhibitor, imatinib* for transition state analogue inhibition, the purine nucleoside phosphorylase inhibitors, forodesine and DADMe-ImmH, as well as the mechanism of the multisubstrate analog inhibitor isoniazid* for slow, tight-binding inhibition, the dipeptidyl peptidase-4 inhibitor, saxagliptin* Chapter 7 (Drug Resistance and Drug Synergism): This new chapter includes topics taken from two chapters in the previous edition, with many new examples* Chapter 8 (Drug Metabolism): Discussions of toxicophores and reactive metabolites* Chapter 9 (Prodrugs and Drug Delivery Systems): Discussion of antibody-drug conjugates

About Richard B. Silverman

Professor Richard B. Silverman received his B.S. degree in chemistry from The Pennsylvania State University in 1968 and his Ph.D. degree in organic chemistry from Harvard University in 1974 (with time off for a two-year military obligation from 1969-1971). After two years as a NIH postdoctoral fellow in the laboratory of the late Professor Robert Abeles in the Graduate Department of Biochemistry at Brandeis University, he joined the chemistry faculty at Northwestern University. In 1986, he became Professor of Chemistry and Professor of Biochemistry, Molecular Biology, and Cell Biology. In 2001, he became the Charles Deering McCormick Professor of Teaching Excellence for three years, and since 2004 he has been the John Evans Professor of Chemistry. His research can be summarized as investigations of the molecular mechanisms of action, rational design, and syntheses of potential medicinal agents acting on enzymes and receptors. His awards include DuPont Young Faculty Fellow (1976), Alfred P. Sloan Research Fellow (1981-1985), NIH Research Career Development Award (1982-1987), Fellow of the American Institute of Chemists (1985), Fellow of the American Association for the Advancement of Science (1990), Arthur C. Cope Senior Scholar Award of the American Chemical Society (2003), Alumni Fellow Award from Pennsylvania State University (2008), Medicinal Chemistry Hall of Fame of the American Chemical Society (2009), the Perkin Medal from the Society of Chemical Industry (2009), the Hall of Fame of Central High School of Philadelphia (2011), the E.B. Hershberg Award for Important Discoveries in Medicinally Active Substances from the American Chemical Society (2011), Fellow of the American Chemical Society (2011), Sato Memorial International Award of the Pharmaceutical Society of Japan (2012), Roland T. Lakey Award of Wayne State University (2013), BMS-Edward E. Smissman Award of the American Chemical Society (2013), the Centenary Prize of the Royal Society of Chemistry (2013), and the Excellence in Medicinal Chemistry Prize of the Israel Chemical Society (2014). Professor Silverman has published over 320 research and review articles, holds 49 domestic and foreign patents, and has written four books (The Organic Chemistry of Drug Design and Drug Action is translated into German and Chinese). He is the inventor of LyricaTM, a drug marketed by Pfizer for epilepsy, neuropathic pain, fibromyalgia, and spinal cord injury pain- currently, he has another CNS drug in clinical trials. Dr. Mark W. Holladay is Vice President of Drug Discovery and Medicinal Chemistry at Ambit Biosciences (San Diego, California) where he leads drug discovery programs in oncology and autoimmune diseases and has contributed to compounds in clinical development. He began his drug hunting career at Abbott Laboratories where he achieved the position of Volwiler Associate Research Fellow as a medicinal chemist and project leader in the Neurosciences Research Area. He also conducted collaborative drug discovery research as a member of contract research organizations including Biofocus and Discovery Partners International. He is a co-author on over 70 peer-reviewed research articles, reviews, or chapters and is named as an inventor on over 40 patents and patent applications. Dr. Holladay earned his undergraduate degree from Vanderbilt University, his Ph.D. at Northwestern University under the direction of Professor Richard B. Silverman, and conducted postdoctoral studies with Professor Daniel H. Rich at the University of Wisconsin-Madison.

Details Book

Author : Richard B. Silverman
Publisher : Academic Press Inc
Data Published : 21 May 2014
ISBN : 0123820308
EAN : 9780123820303
Format Book : PDF, Epub, DOCx, TXT
Number of Pages : 536 pages
Age + : 15 years
Language : English
Rating :

Reviews The Organic Chemistry of Drug Design and Drug Action

17 Comments Add a comment

Related eBooks Download

  • Drug Synthesis Book Set free pdfDrug Synthesis Book Set

    This set presents the authoritative and acclaimed Drug Synthesis books edited by Jie Jack Li and Douglas Johnson: Contemporary Drug Synthesis. The Art of Drug Synthesis. and Modern Drug Synthesis..

  • Green Chemistry Strategies for Drug Discovery free pdfGreen Chemistry Strategies for Drug Discovery

    The incorporation of Green Chemistry is a relatively new phenomenon in the drug discovery discipline. since the scale that chemists operate on in drug discovery is smaller than those of process and manufacturing chemistry..

  • Multifaceted Roles of Crystallography in Modern Drug Discovery (NATO Scienc ... free pdfMultifaceted Roles of Crystallography in Modern Drug Discovery (NATO Scienc ...

    The present work offers a snapshot of the state-of-the-art of crystallographic. analytical. and computational methods used in modern drug design and development. Topics discussed include: drug design against complex systems (membrane proteins..

  • Diet and Drug Interactions free pdfDiet and Drug Interactions

    When we learn from a patient. clinician. or medical record that a drug has been discontinued. it is logical to ask why. The drug may no longer be needed- it may not have produced the desired effect- it may have produced an adverse reaction- a better drug may be available to replace the original drug..

  • Heterocyclic Chemistry in Drug Discovery free pdfHeterocyclic Chemistry in Drug Discovery

    Providing a handy reference to synthetic methods and practical techniques. Heterocyclic Chemistry in Drug Discovery fuses heterocyclic chemistry and drug discovery..

  • The Organic Chemistry of Drug Design and Drug Action free pdfThe Organic Chemistry of Drug Design and Drug Action

    Where To Find Free Ebooks. The Organic Chemistry of Drug Design and Drug Action, Third Edition, represents a unique approach to medicinal chemistry based on physical organic chemical principles and re